Admission of Hematopoietic Cell Transplantation Patients to the Intensive Care Unit at the Pontificia Universidad Católica de Chile Hospital

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 1, 2015, Pages 176-179

  Escobar, Karen ^a   Rojas, Patricio ^a   Ernst, Daniel ^a   Bertin, Pablo ^a   Nervi, Bruno ^a   Jara, Veronica ^a   Garcia, Maria Jose ^a   Ocqueteau, Mauricio ^a   Sarmiento, Mauricio ^a   Ramirez, Pablo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Hematopoietic cell transplantation; Intensive care unit; Outcomes

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE RESPIRATORY FAILURE; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; CHILE; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYCOSIS; MYELOABLATIVE CONDITIONING; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPTIC SHOCK; TREATMENT INDICATION; ALLOTRANSPLANTATION; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RESPIRATORY DISTRESS SYNDROME, ADULT; SHOCK, SEPTIC; STATISTICS AND NUMERICAL DATA; SURVIVAL; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; UNRELATED DONORS;

IMMUNOSUPPRESSIVE AGENT; MYELOABLATIVE AGENT;

ADOLESCENT; ADULT; AGED; CHILE; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; PATIENT ADMISSION; RECURRENCE; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UNRELATED DONORS;

EID: 84927176240     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.08.009     Document Type: Article

References (34)

1. Pawson H., Jayaweera A., Wigmore T. Intensive care management of patients following haematopoietic stem cell transplantation. Curr Anaesth Crit Care 2008, 19:80-90.
2. Torrecilla C., Cortes J.L., Chamorro C., et al. Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy. Intensive Care Med 1988, 14:393-398.
3. Afessa B., Tefferi A., Hoagland H.C., et al. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 1992, 67:117-122.
4. Jackson S.R., Tweeddale M.G., Barnett M.J., et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998, 21:697-704.
5. Price K.J., Thall P.F., Kish S.K., et al. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998, 158:876-884.
6. Scott P.H., Morgan T.J., Durrant S., Boots R.J. Survival following mechanical ventilation of recipients of bone marrow transplants and peripheral blood stem cell transplants. Anaesth Intensive Care 2002, 30:289-294.
7. Crawford S.W., Petersen F.B. Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis 1992, 145:510-514.
8. Martin P.L. To stop or not to stop: how much support should be provided to mechanically ventilated pediatric bone marrow and stem cell transplant patients?. Respir Care Clin N Am 2006, 12:403-419.
9. Lloyd-Thomas A.R., Wright I., Lister T.A., Hinds C.J. Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy. Br Med J (Clin Res Ed) 1988, 296:1025-1029.
10. Brunet F., Lanore J.J., Dhainaut J.F., et al. Is intensive care justified for patients with haematological malignancies?. Intensive Care Med 1990, 16:291-297.
11. Azoulay E., Recher C., Alberti C., et al. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 1999, 25:1395-1401.
12. Benoit D.D., Vandewoude K.H., Decruyenaere J.M., et al. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 2003, 31:104-112.
13. Peigne V., Rusinova K., Karlin L., et al. Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 2009, 35:512-518.
14. Hill Q.A. Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy. Blood Rev 2010, 24:17-25.
15. Afessa B., Tefferi A., Dunn W.F., et al. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med 2003, 31:1715-1721.
16. Barnes R.A., Stallard N. Severe infections after bone marrow transplantation. Curr Opin Crit Care 2001, 7:362-366.
17. Townsend W.M., Holroyd A., Pearce R., et al. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol 2013, 161:578-586.
18. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. JAm Stat Assn 1958, 53:457-481.
19. McDowall K., Hart A., Cadamy A. The outcomes of adult patients with haematological malignancy requiring admission to the intensive care unit. JIntensive Care Soc 2011, 12:112-125.
20. McArdle J.R. Critical care outcomes in the hematologic transplant recipient. Clin Chest Med 2009, 30:155-167.
21. Bach P.B., Schrag D., Nierman D.M., et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001, 98:3234-3240.
22. Soubani A.O., Kseibi E., Bander J.J., et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 2004, 126:1604-1611.
23. Trinkaus M.A., Lapinsky S.E., Crump M., et al. Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplant 2009, 43:411-415.
24. Hawari F.I., Al Najjar T.I., Zaru L., et al. The effect of implementing high-intensity intensive care unit staffing model on outcome of critically ill oncology patients. Crit Care Med 2009, 37:1967-1971.
25. Pene F., Aubron C., Azoulay E., et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. JClin Oncol 2006, 24:643-649.
26. Afessa B., Azoulay E. Critical care of the hematopoietic stem cell transplant recipient. Crit Care Clin 2010, 26:133-150.
27. Yang T.M., Wang P.N., Kao K.C., et al. Outcome of hematopoietic stem cell recipients who were mechanically ventilated and admitted to intensive care units. JFormos Med Assoc 2007, 106:295-301.
28. Kim S.W., Kami M., Urahama N., et al. Feasibility of acute physiology and chronic health evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation. Transplantation 2003, 75:566-570.
29. Neumann F., Lobitz O., Fenk R., et al. The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation. Ann Hematol 2008, 87:299-304.
30. Kaukonen K.M., Bailey M., Suzuki S., et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014, 311:1308-1316.
31. Levy M.M., Artigas A., Phillips G.S., et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012, 12:919-924.
32. Legrand M., Max A., Peigne V., et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012, 40:43-49.
33. Kersting S., Koomans H.A., Hené R.J., Verdnock L.F. Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant 2007, 39:359-365.
34. Parikh Ch, Schrier R., Storer B., et al. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis 2005, 45:502-509.